Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H26N8O6S2 |
| Molecular Weight | 550.611 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[N+]34CCC(CC3)(CC4)C(N)=O)=C(N2C1=O)C([O-])=O)C5=NSC(N)=N5
InChI
InChIKey=JUVHVMCKLDZLGN-TVNFHGJBSA-N
InChI=1S/C21H26N8O6S2/c1-35-26-11(14-25-20(23)37-27-14)15(30)24-12-16(31)28-13(18(32)33)10(9-36-17(12)28)8-29-5-2-21(3-6-29,4-7-29)19(22)34/h12,17H,2-9H2,1H3,(H5-,22,23,24,25,27,30,32,33,34)/b26-11-/t12-,17-,21?,29?/m1/s1
| Molecular Formula | C21H26N8O6S2 |
| Molecular Weight | 550.611 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Cefclidin is a fourth-generation cephalosporin antibiotic effective against a clinical strain of Citrobacter freundii. The affinity of cefclidin for the β-lactamase isolated from these mutants was lower than that of ceftazidime, and the kinetic parameters of enzymatic hydrolysis showed that cefclidin was hydrolyzed more slowly at a low concentration than was ceftazidime. It is suggested that the high activity of cefclidin against strains derepressed for β-lactamase plays a major role in the absence of emergence of resistant mutants.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:56:59 GMT 2025
by
admin
on
Wed Apr 02 08:56:59 GMT 2025
|
| Record UNII |
78963CJ0OG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C357
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
105239-91-6
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
SUB07384MIG
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
C056494
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
m629
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
6537446
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
6705
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
3484
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
100000081815
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
78963CJ0OG
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
DTXSID80147023
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
Cefclidin
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
C98220
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY | |||
|
CHEMBL1614665
Created by
admin on Wed Apr 02 08:56:59 GMT 2025 , Edited by admin on Wed Apr 02 08:56:59 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |